Symplr finds 3% clinician support

Hospital supply chain work sounds like contracts and cartons. But in healthcare, it also decides which implants, devices, and supplies clinicians can use at the bedside. That is why symplr’s January 20, 2026 survey landed as more than a procurement story. The big news was not just that supply leaders feel squeezed by disruptions and savings targets. It was that clinician alignment looks alarmingly thin — with only 3% saying clinicians actively support supply-chain initiatives. ### What did symplr actually release? Symplr released its third annual State of Healthcare Supply Chain Survey and framed 2026 as a “dual crisis.” Leaders said they are still dealing with disruptions, but now they are also under heavier pressure to deliver savings. More than half — 53% — expect supply-chain challenges to worsen or stay the same in 2026, while 80% expect higher savings targets. ### Why is the 3% number such a big deal? Because it points to a legitimacy problem, not just a workflow problem. Hospitals can centralize contracts and push standardization, but those decisions hit real clinical preferences — surgeons, physicians, nurses, and procedural teams often care deeply about which products they use. If only 3% of supply leaders strongly feel clinicians support these initiatives, the system is running with very little active buy-in. ### Is this just about “doctors resisting cost cuts”? Not really. The survey points to a broader integration gap. Only 32% of respondents said their supply chain is fully clinically integrated. That means many hospitals still have a structural divide between the people asked to reduce variation and cost, and the people making product choices in operating rooms, cath labs, and patient care units. ### Why does that gap hurt patient care and efficiency? Because healthcare products are not interchangeable in the simple consumer-goods sense. A device choice can affect workflow, training, outcomes, and physician preference all at once. When supply teams and clinicians are misaligned, hospitals get slower approvals, more exceptions, weaker standardization, and less cultural areas directly affect both cost and care. ### What is making this worse right now? The pressure is stacking. Material shortages were the top concern in symplr’s infographic, and nearly half of respondents expected savings targets to rise by at least 5 percentage points. On top of that, 41% said at least 30% of their time is eaten up by day-to-day fire drills. Basically, teams are being asked to think strategically while operating in constant triage mode. ### So what are hospitals supposed to do differently? The answer is less “procurement gets tougher” and more “governance gets smarter.” Symplr argues for bringing clinicians in earlier, using shared evidence and benchmarking in product decisions, and grounding value analysis in outcomes as well as price. McKinsey’s physician survey points the same way — build processes that actually fit physician decision-making, instead of treating clinician engagement as a late-stage signoff. ### Why does this matter beyond supply-chain teams? Because hospitals are now trying to protect margins without looking like they are rationing care. That only works if product standardization feels clinically defensible. The catch is that finance logic alone will not get you there. Hospitals need clinicians to help choose, validate, and live with the products that end up on contract. ### Bottom line? The 3% figure is a warning flare. Hospitals do not just have a sourcing problem in 2026. They have a trust-and-governance problem — and until clinicians and supply leaders are solving the same problem together, cost pressure will keep colliding with care delivery.